Massive Bio As

Today, May 20, is International Clinical Trials Day.

Clinical trials are how medicine moves forward. But for too long, finding the right trial has been one of the hardest parts of a cancer diagnosis.

At Massive Bio, we exist to change that. Our AI has matched over 190,000 patients to clinical trials across 17 countries, so that geography, complexity, and time never stand between a patient and a potentially life-changing option.

Every match matters. Every trial matters. Every patient matters.

Big news. Massive Bio has officially earned the DiMe Seal and joined the CMS Medicare App Library.

This means our platform has been independently verified for clinical evidence, privacy, usability, and security, and is now accessible to over 68 million Medicare beneficiaries through a federally recognized channel.

For every cancer patient searching for the right trial, this is one more reason to trust the journey with us.

We have been nominated at the 30th Annual Webby Awards in the AI - Healthcare and Life Sciences category, placing us among the top 11% of over 13,000 entries worldwide. 🏆

The People's Voice Award is decided by public votes. Voting is open until April 16th. 🗓️

Your vote helps more cancer patients access clinical trials worldwide. 🌍

Vote here: https://vote.webbyawards.com/PublicVoting #/2026/ai/ai-experiences-applications/healthcare-life-sciences